COO Brutnell presents at the 4th Annual Inner Ear Disorders Therapeutics Summit in Boston, MA

• Exploring Novel Small Molecule & Gene Therapeutic Approaches for Tinnitus Indications for Improved Patient Care

• Discussing the expansion of the gene therapy field into a wider host of disease targets and increased patient populations

• Uncovering safety, immunogenicity, and dosing challenges for different patient populations outside hearing disorders

• Dive deep into the exciting new advancements and technologies in gene therapy for other disease indications